Abstract 4372: Proteolysis-targeting vaccines, or PROTAX, for robust tumor combination immunotherapy
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: University of Michigan
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148797448
Cites:
Cited by:
Related to:
